Ducressa 1 mg / mL & 5 mg / mL, collyre en solution

7680681650010 CH-68165 Augentropfen

Associated product:

DUCRESSA gtt opht fl 5 ml
Ducressa 1 mg / mL & 5 mg / mL, collyre en solution
Ducressa 1 mg / mL & 5 mg / mL, collyre en solution
Ducressa 1 mg / mL & 5 mg / mL, collyre en solution
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
ml
Galenic form
Augentropfen
Galenic group
Augenmittel

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
levofloxacinum
5.0 MG Substance Wirkstoff (Principe actif)
levofloxacinum hemihydricum
- Substance WIZUS
dexamethasonum
1.0 MG Substance Wirkstoff (Principe actif)
dexamethasoni natrii phosphas
- Substance WIZUS
benzalkonii chloridi solutio
0.1 MG Substance HBESI
natrii dihydrogenophosphas monohydricus
- Substance HNIDK
dinatrii phosphas dodecahydricus
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum dilutum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
phosphas
4.01 MG Substance HBESI

Authorization holder

Santen SA

1202 Genève

Authorization information

Swissmedic authorization number
68165
Drug name
Ducressa, collyre en solution
Galenic form
AUL
ATC Code
S01CA01
Authorization status
Z
Dispensing category
A
First authorization
26/03/2021
Authorization expiration date
31/12/9999
IT Number
11.06.1.
Domain
Human medicine

Package details

Description (FR)
DUCRESSA gtt opht fl 5 ml
Description (DE)
DUCRESSA Gtt Opht Fl 5 ml
Market launch
26/03/2021
Narcotic (BTM)
No
Buy us a coffee Explore the data